Biotech Startups
10,023 companies tagged Biotech, with their investors and founders.
Ikaika Therapeutics develops treatments for cardiovascular disease using genetic signals, with a focus on inherited forms of heart disease and neuromuscular genetic disorders such as myopathies and muscular dystrophy. The company applies research on the genetic causes and mechanisms of cardiac disorders to drive drug development.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
ImageProVision develops imaging-based analysis software for particle characterization, microbial enumeration, thermal analysis, and packaging inspection used by pharmaceutical, biotech, and industrial laboratories. The CLAIRITY suite provides automated and AI-powered tools for microscopy analysis across regulated manufacturing and research environments.
0 investors
0 investors
0 investors
0 investors
0 investors
Imanis Life Sciences is a contract research organization staffed by virologists, immunologists, molecular biologists, and assay scientists that provides laboratory and development services to help clients accelerate therapy development.
0 investors
0 investors
ImCare Biotech develops diagnostic biomarkers and therapeutic drugs targeting liver diseases, including hepatocellular carcinoma and intrahepatic cholangiocarcinoma. The company conducts research and development in molecular biology and tissue cultures.
0 investors
0 investors
0 investors
Immunaeon provides cellular banking and cryopreservation services, helping individuals preserve their healthiest cells for potential future medical use. The company serves patients seeking to maintain medical options through cell preservation, with an emphasis on clear communication and privacy protection.
0 investors
0 investors
Immuneering develops Deep Cyclic Inhibitors, a class of oncology medicines designed to pulse dosing faster than cancer's adaptive mechanisms to limit resistance and reduce side effects. The company targets more durable tumor control and improved tolerability for cancer patients.
0 investors
ImmuneSensor Therapeutics is a clinical-stage biotechnology company developing orally available small molecule cGAS inhibitors that target the cGAS-STING innate immune pathway to treat inflammatory and autoimmune diseases. Founded on research from UT Southwestern Medical Center, it advances a pipeline of drug candidates for immune-related conditions.
0 investors